Trials / Completed
CompletedNCT02873910
Influence of IQPAS-119 on Post-Marathon Susceptibility to Infections and Others
Randomized, Double-Blind, Placebo-Controlled, Monocentric, Parallel-Group Study to Evaluate the Influence of IQPAS-119 on Post-Marathon Susceptibility to Infections and Influence on Other Complaints and Its Tolerability: A Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- InQpharm Group · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the benefit and tolerability of IQP-AS-119 for reduction of susceptibility to infections and other complaints after extreme physical stress (participation in a marathon).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | IQP-AS-119 | |
| DIETARY_SUPPLEMENT | Placebo |
Timeline
- Start date
- 2016-07-10
- Primary completion
- 2016-10-31
- Completion
- 2016-10-31
- First posted
- 2016-08-22
- Last updated
- 2018-01-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02873910. Inclusion in this directory is not an endorsement.